Nobel Prize Recognizes Pioneering Body's Defenses Discoveries
This year's prestigious award in medical science was granted for transformative discoveries that clarify how the immune system targets dangerous infections while protecting the healthy tissues.
A trio of renowned scientists—from Japan Shimon Sakaguchi and American experts Dr. Brunkow and Dr. Ramsdell—received this honor.
The research identified unique "sentinels" within the immune system that eliminate malfunctioning immune cells capable of harming the body.
The findings are now enabling new treatments for immune disorders and cancer.
The winners will share a prize fund valued at 11 million Swedish kronor.
Crucial Discoveries
"Their research has been essential for understanding how the immune system functions and why we do not all develop serious autoimmune diseases," commented the head of the Nobel Committee.
The team's research address a fundamental question: How does the immune system defend us from countless infections while leaving our own tissues unharmed?
The body's protection system employs immune cells that search for indicators of disease, even pathogens and bacteria it has never encountered.
These defenders utilize detectors—known as receptors—that are generated by chance in a vast number of combinations.
This provides the defense network the capacity to fight a wide array of invaders, but the unpredictability of the process inevitably produces white blood cells that can attack the body.
Protectors of the Immune System
Researchers earlier understood that some of these harmful white blood cells were destroyed in the immune organ—the site where immune cells mature.
This year's Nobel Prize recognizes the identification of T-reg cells—known as the immune system's "peacekeepers"—which travel through the body to disarm any defenders that assault the body's own tissues.
We know that this mechanism malfunctions in autoimmune diseases such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.
The Nobel panel added, "The findings have established a novel area of research and spurred the creation of innovative treatments, for example for tumors and immune disorders."
In malignancies, T-regs block the system from fighting the tumor, so studies are aimed at reducing their quantity.
For autoimmune diseases, trials are exploring increasing regulatory T-cells so the body is not under attack. A similar method could also be useful in reducing the risks of transplanted organ rejection.
Pioneering Experiments
Prof Shimon Sakaguchi, from Osaka University, conducted experiments on rodents that had their thymus removed, leading to self-attack conditions.
The researcher demonstrated that injecting defense cells from other animals could prevent the illness—implying there was a system for preventing immune cells from harming the host.
Dr. Brunkow, affiliated with the a research center in Seattle, and Dr. Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were investigating an genetic immune disorder in mice and humans that led to the identification of a genetic factor critical for how regulatory T-cells operate.
"The groundbreaking research has uncovered how the body's defenses is kept in check by regulatory T cells, preventing it from mistakenly attacking the healthy cells," commented a leading physiology expert.
"This research is a remarkable illustration of how fundamental biological research can have broad consequences for human health."
